Nav: Home

Andrea Cheville, M.D., of Mayo Clinic elected to the National Academy of Medicine

October 19, 2016

ROCHESTER, Minn. -- Andrea Cheville, M.D., physical medicine and rehabilitation researcher and director of the Cancer Rehabilitation Program at Mayo Clinic, has been elected to the National Academy of Medicine.

Being elected to the academy, formerly known as the Institute of Medicine, is considered one of the highest honors in health and medicine.

Dr. Cheville is one of two Mayo Clinic physicians to be elected this year. Orthopedic surgeon and researcher Michael Yaszemski, M.D., Ph.D., also was selected.

"To have colleagues from distinct practice areas recognized in the same year is an incredible honor for them individually and for Mayo Clinic as a whole," says John Noseworthy, M.D., president and CEO, Mayo Clinic. "Such recognition underscores the commitment of our physician-scientists in advancing research to address unmet patient needs, educating the next generation of physicians and scientists, and providing unparalleled care for patients and their families.

" Dr. Cheville is well-known for developing patient-centric, cost-effective strategies for delivering supportive care to people with complex and chronic conditions. Her clinical and research interests are cancer rehabilitation, lymphedema and palliative medicine. She has examined factors that cause people with cancer and other chronic conditions to lose function and shown that these factors are widely undertreated, especially in the outpatient setting.

Dr. Cheville is professor and chair of research in the Department of Physical Medicine and Rehabilitation on Mayo Clinic's Rochester campus, where she directs the cancer rehabilitation and lymphedema clinic. She is medical director for the Care Experience Program in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.

Dr. Cheville earned her medical degree from Harvard Medical School in 1993 and her master of science degree in clinical epidemiology from the University of Pennsylvania in 2006. She is board?certified in physical medicine and rehabilitation, pain medicine, and hospice and palliative medicine.

In June 2016, she was appointed to the Health Services Organization and Delivery Study Section in the National Institutes of Health Center for Scientific Review. This group, which is made up of experts in health care delivery, reviews complex and multidisciplinary grant applications for possible funding.

"Dr. Cheville's research has brought significant improvements in identifying, preventing and remediating disability in people with chronic illness," Dr. Noseworthy says. "Her work has led to innovations in clinical practice at our cancer rehabilitation and lymphedema clinic, namely integrating palliative principles into the holistic rehabilitation of patients with late-stage cancer."

Dr. Cheville also has worked extensively with trainees characterizing the epidemiology of function loss, developing algorithms to predict disability and extending collaborative care models to the delivery of function-directed care.

Dr. Cheville has received research funding from the National Institutes of Health, National Cancer Institute, and the U.S. Department of Defense.

Established as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine and related policy. Current active members elect new members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care and public health. Once elected, members commit to volunteering their service in the academies' activities. One of four national academies, it is based in Washington, D.C.
-end-
Other physicians who have been elected to the academy while at Mayo Clinic include: Clifford Jack, M.D. (2013), Richard Ehman, M.D. (2010), Denis Cortese, M.D. (2005), Andrew Engel, M.D. (2003), and the late Thoralf M. Sundt, M.D. (1991). The National Academy of Medicine has about 1,800 active members.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org.

Mayo Clinic

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...